A detailed history of Qube Research & Technologies LTD transactions in Augmedix, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 15,433 shares of AUGX stock, worth $36,267. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,433
Previous 222,000 93.05%
Holding current value
$36,267
Previous $907,000 98.57%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.75 - $4.18 $154,925 - $863,450
-206,567 Reduced 93.05%
15,433 $13,000
Q1 2024

May 14, 2024

BUY
$3.2 - $5.83 $386,332 - $703,850
120,729 Added 119.21%
222,000 $907,000
Q4 2023

Feb 13, 2024

BUY
$4.34 - $5.93 $419,079 - $572,612
96,562 Added 2050.58%
101,271 $592,000
Q3 2023

Nov 13, 2023

BUY
$3.91 - $5.3 $18,412 - $24,957
4,709 New
4,709 $24,000

Others Institutions Holding AUGX

About Augmedix, Inc.


  • Ticker AUGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,421,200
  • Market Cap $87.9M
  • Description
  • Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes...
More about AUGX
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.